Research Areas of Interest and Highlights
Dr. Gellad’s research focuses on the quality, safety, and efficiency of prescribing. He is the recipient of a VA (Department of Veterans Affairs) Career Development Award to study how and why the use of high-cost drugs varies across the VA system among patients with diabetes. He is currently studying the role of formulary management within the VA in affecting high-cost drug use. Dr. Gellad is the author of several reviews on the barriers to medication adherence and has additionally studied the role of prescription costs in affecting medication use, as well as the use of $4 generic drugs from retail pharmacies and the use of antipsychotic medications in nursing homes.
Education and Background
- MPH, Harvard School of Public Health
- Chief Resident, Brigham and Women's Hospital/Harvard Medical School
- Fellow, Brigham and Women's Hospital/Harvard Medical School, General Medicine
- Resident, Brigham and Women’s Hospital, Internal Medicine
- MD, University of Maryland School of Medicine
- BA, Swarthmore College, Music
Dr. Gellad joined the faculty of the University of Pittsburgh in 2008 where he is an Assistant Professor of Medicine in the School of Medicine and an Assistant Professor of Health Policy and Management in the Graduate School of Public Health. He is also an Adjunct Scientist at the RAND Corporation.
Dr. Gellad is a core faculty member with the VA Center for Health Equity Research and Promotion (CHERP) and a primary care physician in the VA Pittsburgh Healthcare System. He is a member of the Food and Drug Administration (FDA) Nonprescription Drugs Advisory Committee as well as an alternate member of the FDA Drug Safety Oversight Board.